Vincenzo Valentini, Hans-Joachim Schmoll, Cornelis J.H. van de Velde, editors.
EDITION STATEMENT
Edition Statement
Second edition.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Cham, Switzerland :
Name of Publisher, Distributor, etc.
Springer,
Date of Publication, Distribution, etc.
2018.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references.
CONTENTS NOTE
Text of Note
Intro; Foreword; Preface; Contents; 1: What Is Cancer of the Rectum?; 1.1 Epidemiology; 1.2 The Rectum; 1.2.1 Anatomy; 1.2.2 Function; 1.3 Pathophysiology; 1.4 Presentation; 1.5 Diagnosis; References; 2: The Patient's Perspective; 2.1 What Is Known About the Patient's Endpoints?; 2.2 Variation in Information; 2.3 What Are Relevant Endpoints?; 2.4 Does Type of Surgery Influence Functional Outcome in Rectal Cancer?; 2.5 Is Bowel Function After Sphincter-Saving Surgery a Relevant Endpoint for Patients?; 2.6 Is Having a Stoma a Relevant Endpoint for Patients?
Text of Note
2.7 Is Sexual Function a Relevant Endpoint for Patients?2.8 Is Bladder Function a Relevant Endpoint for Patients?; 2.9 Is Emotional Function a Relevant Endpoint for Patients?; 2.10 Is Pain a Relevant Endpoint for Patients?; 2.11 Is Tiredness a Relevant Endpoint for Patients?; 2.12 Is Radiotherapy's Effect a Relevant Endpoint for the Patients?; 2.13 Future Perspectives; References; 3: What Are the Issues in the Treatment of Elderly Patients?; 3.1 Introduction; 3.2 What Is Frailty and How Is Frailty Easily Assessed?
Text of Note
3.3 What Is the Treatment of Choice in a Physiologically Fit Elderly?3.4 Stoma or Bowel Continuity?; 3.5 What to Do in an Emergency Situation?; 3.6 Expectations of Life and Shared Decision Making; 3.7 Future Developments; 3.8 Summary; References; 4: Are There Risk Factors in the European Population, Which Promote Rectal Cancer and/or Favour Curability?; 4.1 Introduction; 4.2 Age and Stage at Diagnosis as Prognostic Factors for Rectal Cancer; 4.3 Modifiable Risk Factors; 4.3.1 Prevalence of Comorbidity Among Rectal Cancer Patients; 4.3.2 Effect of Comorbidity on Choice of Treatment.
Text of Note
4.3.3 Effect of Comorbidity on Postoperative Mortality4.3.4 Effect of Comorbidity on Overall Survival; 4.4 Screening Consequences on Rectal Cancer Diagnosis and Prognosis; 4.5 Genetic Risk and Rectal Cancer; References; 5: What Is the History of Rectal Cancer Treatment?; 5.1 How Did Rectal Cancer Turn into Curable Disease?; 5.1.1 Perineal and Sacral Resection; 5.2 How Did Sphincter Preservation Become the New Golden Standard?; 5.3 What Was the Most Important Milestone in Rectal Cancer Surgery After the Introduction of Miles' APR?
Text of Note
5.4 How Did the Focus Change from Eradication of the Tumour Only to Combining Cure with Quality of Life of Patients After Treatment?5.5 What Have Been the Developments in Minimally Invasive Surgery for Rectal Cancer?; 5.5.1 Laparoscopic Rectal Cancer Surgery; 5.5.2 Rectum-Saving Therapy; 5.6 How Did (Neo)Adjuvant Therapies Improve Treatment of Rectal Cancer?; 5.7 Can Imaging Techniques Represent the Next Step in the Development of Rectal Cancer Treatment?; References.
0
8
8
8
8
SUMMARY OR ABSTRACT
Text of Note
In this book, a distinguished group of clinicians provide straightforward, focused answers to the questions most commonly confronted by a multidisciplinary team when caring for patients with rectal cancer. The format of the book is designed to aid optimal decision making in a multidisciplinary setting with respect to key issues in imaging, radiotherapy, chemotherapy, and surgery, all of which are considered in detail. Helpful guidance is also offered on risk factor identification, pathology procedures and their prognostic value, and multidisciplinary team management. The authors have been carefully selected for their expertise, and most have been involved in the management of the more significant trials published in Europe during the past decade. In an era in which all patients are entitled to access healthcare systems that deliver the highest quality of treatment within a safe environment, together with appropriate advice, support, and long-term follow-up, the multidisciplinary team is of central importance. This successful book, in its revised and updated second edition, is designed to provide all the guidance likely to be required by members of the multidisciplinary team at various stages of the pathway of care for patients with rectal cancer.